Guerbet S. A. (GBT) - Total Liabilities
Based on the latest financial reports, Guerbet S. A. (GBT) has total liabilities worth €669.94 Million EUR (≈ $783.23 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Guerbet S. A. (GBT) net asset momentum to track the company's year-over-year net asset growth rate.
Guerbet S. A. - Total Liabilities Trend (2004–2025)
This chart illustrates how Guerbet S. A.'s total liabilities have evolved over time, based on quarterly financial data. See GBT free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Guerbet S. A. Competitors by Total Liabilities
The table below lists competitors of Guerbet S. A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nelly Group AB
ST:NELLY
|
Sweden | Skr547.40 Million |
|
Nicolas Correa SA
MC:NEA
|
Spain | €65.16 Million |
|
Tata Steel (Thailand) Public Company Limited
F:MVX
|
Germany | €2.96 Billion |
|
Tung Ho Textile Co Ltd
TW:1414
|
Taiwan | NT$1.04 Billion |
|
Accel Solutions Group Ltd
TA:ACCL
|
Israel | ILA292.30 Million |
|
Bright Led Electronics Corp
TW:3031
|
Taiwan | NT$538.98 Million |
|
Fonar Corporation
NASDAQ:FONR
|
USA | $54.36 Million |
|
Devyser Diagnostics AB
ST:DVYSR
|
Sweden | Skr112.20 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Guerbet S. A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Guerbet S. A..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guerbet S. A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guerbet S. A. (2004–2025)
The table below shows the annual total liabilities of Guerbet S. A. from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €669.94 Million ≈ $783.23 Million |
+3.76% |
| 2024-12-31 | €645.68 Million ≈ $754.87 Million |
-0.20% |
| 2023-12-31 | €646.97 Million ≈ $756.38 Million |
+15.52% |
| 2022-12-31 | €560.07 Million ≈ $654.78 Million |
-5.99% |
| 2021-12-31 | €595.74 Million ≈ $696.48 Million |
+3.08% |
| 2020-12-31 | €577.95 Million ≈ $675.69 Million |
-6.73% |
| 2019-12-31 | €619.68 Million ≈ $724.47 Million |
-13.22% |
| 2018-12-31 | €714.05 Million ≈ $834.80 Million |
+16.78% |
| 2017-12-31 | €611.45 Million ≈ $714.85 Million |
-14.28% |
| 2016-12-31 | €713.35 Million ≈ $833.98 Million |
+15.05% |
| 2015-12-31 | €620.06 Million ≈ $724.91 Million |
+186.36% |
| 2014-12-31 | €216.53 Million ≈ $253.15 Million |
-2.15% |
| 2013-12-31 | €221.29 Million ≈ $258.72 Million |
-5.73% |
| 2012-12-31 | €234.76 Million ≈ $274.46 Million |
-0.07% |
| 2011-12-31 | €234.92 Million ≈ $274.65 Million |
+11.08% |
| 2010-12-31 | €211.49 Million ≈ $247.26 Million |
+11.89% |
| 2009-12-31 | €189.01 Million ≈ $220.98 Million |
-4.17% |
| 2008-12-31 | €197.23 Million ≈ $230.58 Million |
+5.89% |
| 2007-12-31 | €186.26 Million ≈ $217.75 Million |
+6.81% |
| 2006-12-31 | €174.37 Million ≈ $203.86 Million |
+12.75% |
| 2005-12-31 | €154.65 Million ≈ $180.81 Million |
+14.17% |
| 2004-12-31 | €135.46 Million ≈ $158.37 Million |
-- |
About Guerbet S. A.
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconne… Read more